73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Increased adenoma detection rate may significantly reduce post-colonoscopy colorectal cancer risk

Increased adenoma detection rate may significantly reduce post-colonoscopy colorectal cancer risk

byAmerican College of PhysiciansCredit: Pixabay/CC0 Public DomainA cohort study from the Italian Colorectal Cancer screening program including more than 49,000 colonoscopies found a significant

Increased adenoma detection rate may significantly reduce post-colonoscopy colorectal cancer risk

byAmerican College of PhysiciansCredit: Pixabay/CC0 Public DomainA cohort study from the Italian Colorectal Cancer screening program including more than 49,000 colonoscopies found a significant
Researchers look to the gut to boost cancer immunotherapy's fighting power

Researchers look to the gut to boost cancer immunotherapy's fighting power

by Harvard Medical SchoolCredit: Pixabay/CC0 Public DomainCancer immunotherapy has transformed the treatment of many types of cancer. Yet, for reasons that remain poorly understood, not all patie

Researchers look to the gut to boost cancer immunotherapy's fighting power

by Harvard Medical SchoolCredit: Pixabay/CC0 Public DomainCancer immunotherapy has transformed the treatment of many types of cancer. Yet, for reasons that remain poorly understood, not all patie
Scientists discover how excessive red meat consumption increases colorectal cancer risk

Scientists discover how excessive red meat consumption increases colorectal cancer risk

byAgency for Science, Technology and Research (A*STAR), SingaporeIdentification of SP2509 and its target Pirin as a regulator of hTERT in colorectal cancer. Credit:Cancer Discovery(2

Scientists discover how excessive red meat consumption increases colorectal cancer risk

byAgency for Science, Technology and Research (A*STAR), SingaporeIdentification of SP2509 and its target Pirin as a regulator of hTERT in colorectal cancer. Credit:Cancer Discovery(2
Researchers report on intrathoracic synovial sarcoma with BRAF V600E mutation

Researchers report on intrathoracic synovial sarcoma with BRAF V600E mutation

by Impact Journals LLC(A) Axial T2 MR shows a heterogeneous mass in the cardiophrenic space with evidence of anterior chest wall invasion and intercostal invasion. (B) Axial T2 MR shows 35 % of reduct

Researchers report on intrathoracic synovial sarcoma with BRAF V600E mutation

by Impact Journals LLC(A) Axial T2 MR shows a heterogeneous mass in the cardiophrenic space with evidence of anterior chest wall invasion and intercostal invasion. (B) Axial T2 MR shows 35 % of reduct
Women may not recognize non-lump symptoms of breast cancer

Women may not recognize non-lump symptoms of breast cancer

by Lori SolomonFewer than half of women recognize symptoms other than a lump in the breast as a potential sign of breast cancer, according to the results of a survey commissioned by The Ohio State Uni

Women may not recognize non-lump symptoms of breast cancer

by Lori SolomonFewer than half of women recognize symptoms other than a lump in the breast as a potential sign of breast cancer, according to the results of a survey commissioned by The Ohio State Uni
Metastatic cancers adapt their metabolism to the tissue in which they grow

Metastatic cancers adapt their metabolism to the tissue in which they grow

by Ulrika Ernström,Chalmers University of TechnologyMetastatic tumors adapt their metabolism to the tissue in which they grow. The image shows a primary breast cancer tumour (pink) and the metas

Metastatic cancers adapt their metabolism to the tissue in which they grow

by Ulrika Ernström,Chalmers University of TechnologyMetastatic tumors adapt their metabolism to the tissue in which they grow. The image shows a primary breast cancer tumour (pink) and the metas
Researchers identify feature of early stage colorectal cancer tumors that signals aggressiveness

Researchers identify feature of early stage colorectal cancer tumors that signals aggressiveness

by Cheryl Critchley,Monash UniversityOncogenic KRAS-driven MAPK signaling confers tolerance to epithelial TGFβ activation. a Representative H&E and Alk5 ISH of small intestinal tissue from V

Researchers identify feature of early stage colorectal cancer tumors that signals aggressiveness

by Cheryl Critchley,Monash UniversityOncogenic KRAS-driven MAPK signaling confers tolerance to epithelial TGFβ activation. a Representative H&E and Alk5 ISH of small intestinal tissue from V
How tumors suppress the development of metastases

How tumors suppress the development of metastases

byGerman Cancer Research CenterCredit:Journal of Experimental Medicine(2022). DOI: 10.1084/jem.20202595Why do metastases often only appear after the original tumor has been surgicall

How tumors suppress the development of metastases

byGerman Cancer Research CenterCredit:Journal of Experimental Medicine(2022). DOI: 10.1084/jem.20202595Why do metastases often only appear after the original tumor has been surgicall
Study reveals how patients' smoking history changes evolution of lung cancer

Study reveals how patients' smoking history changes evolution of lung cancer

by Walter and Eliza Hall InstituteThis immunofluorescence image shows the presence of a specific subset of T cells (tissue-resident memory T cells, TRM) in the lung of smoker patients. The TRM ce

Study reveals how patients' smoking history changes evolution of lung cancer

by Walter and Eliza Hall InstituteThis immunofluorescence image shows the presence of a specific subset of T cells (tissue-resident memory T cells, TRM) in the lung of smoker patients. The TRM ce
Final overall study analysis continues to show benefit of sacituzumab govitecan in advanced HR+ breast cancer

Final overall study analysis continues to show benefit of sacituzumab govitecan in advanced HR+ breast cancer

byDana-Farber Cancer InstituteOverall survival in the intention-to-treat population. This is the planned final analysis of overall survival in the intent-to-treat population of all randomly assi

Final overall study analysis continues to show benefit of sacituzumab govitecan in advanced HR+ breast cancer

byDana-Farber Cancer InstituteOverall survival in the intention-to-treat population. This is the planned final analysis of overall survival in the intent-to-treat population of all randomly assi
Study shines light on gut microbiome in colon cancer

Study shines light on gut microbiome in colon cancer

by American Society for MicrobiologyMicroRNA and mRNA visualization in differentiating C1C12 cells. Credit: Ryan Jeffs/WikipediaResearchers have identified a correlation between gut microbial com

Study shines light on gut microbiome in colon cancer

by American Society for MicrobiologyMicroRNA and mRNA visualization in differentiating C1C12 cells. Credit: Ryan Jeffs/WikipediaResearchers have identified a correlation between gut microbial com
ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris

ASH: A+CHP bests CHOP for peripheral T-cell lymphoma

(HealthDay)—For patients with CD30-positive peripheral T-cell lymphoma, brentuximab vedotin, cyclophosphamide, doxorubicin, and prednisone (A+CHP) is superior to cyclophosphamide, doxorubicin, vincris